テキサスにおける泌尿生殖器がんの臨床試験
テキサス内の拠点で、泌尿生殖器がんに関する10件の研究が参加者を募集しています。
テキサス内の都市
公式研究テキスト（英語）
Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
- Texas Oncology, Austin
- Texas Oncology - Northeast Texas, Tyler
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/30更新 · NCT07566156Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- UT Southwestern Simmons Cancer Center - RedBird, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
- UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth
- 他1件
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/30更新 · NCT03866382uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
- UT Southwestern Medical Center, Dallas
- The University of Texas M.D. Anderson Cancer Center, Houston
被験者募集中観察研究
18歳以上 · 全性別 · 2026/09/29更新 · NCT05874921Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
- NEXT Oncology, Austin
- MD Anderson Cancer Center, Houston
被験者募集中第1/2相
18歳以上 · 男性 · 2026/09/25更新 · NCT06800313Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
- M D Anderson Cancer Center, Houston
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/18更新 · NCT04038619Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer
- Investigational Site Number: 401, Houston
被験者募集中第1相
18歳以上 · 男性 · 2026/09/10更新 · NCT05997615A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
- The University of Texas, MD Anderson Cancer Center, Houston
- UT Health Mays Cancer Center, San Antonio
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/11更新 · NCT05592626Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer
- M D Anderson Cancer Center, Houston
被験者募集中第1相
18歳以上 · 全性別 · 2026/07/15更新 · NCT03819296A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
- USA Clinical Trials, San Antonio
被験者募集中第1相
18歳以上 · 男性 · 2026/07/09更新 · NCT07103018Prospective Data Registry and Quality of Life Assessment of Patients Undergoing Radiotherapy With the RefleXion Medical Radiotherapy System
- UT Southwestern, Dallas
被験者募集中観察研究
全年齢 · 全性別 · 2025/08/15更新 · NCT05406167ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。